GRIA2 and neurodegenerative disease: It is worth noting that decreased expression of ADAR2 has been observed in other neurodegenerative diseases, including ALS [131] and forebrain ischemia [44] and the resulting impairment of GluA2 Q/R site editing is thought to be linked to neuronal death in these conditions.